FTC Crackdowns on GLP-1 Scams: Protecting Yourself from Fraud
The explosive demand for GLP-1 medications has attracted scammers, fake supplement sellers, and deceptive providers. The FTC is fighting back, and you need to know what to watch for.
The GLP-1 medication market's rapid growth has created fertile ground for fraud. From supplements falsely claiming to replicate Ozempic's effects to unlicensed sellers offering prescription medications without proper oversight, the scam landscape is vast. The Federal Trade Commission (FTC) has stepped up enforcement, but consumers remain the first line of defense.
Disclaimer
This article provides consumer protection information and is not legal advice. Report suspected fraud to the FTC at ReportFraud.ftc.gov.
The GLP-1 Scam Landscape
The FTC has identified several categories of GLP-1-related fraud. Fake supplements represent the largest category: products marketed as "natural Ozempic," "herbal GLP-1 activators," or "semaglutide alternatives" that contain no active GLP-1 compounds and have no clinical evidence supporting their claims. These products often use before-and-after photos, fake testimonials, and scientific-sounding language to deceive consumers.
Unlicensed sellers offer what they claim is prescription semaglutide or tirzepatide without proper medical evaluation, often from foreign sources. These products may be counterfeit, contaminated, improperly dosed, or expired. Deceptive pricing schemes advertise low prices but add hidden fees, mandatory subscription minimums, or charge for consultations that were advertised as free.
Red Flags to Watch For
- No prescription required: Legitimate GLP-1 medications always require a valid prescription
- "Natural alternative" claims: No supplement replicates GLP-1 medication effects
- Guaranteed results: No medical treatment can guarantee specific outcomes
- Foreign pharmacy sources: Higher risk of counterfeit or contaminated products
- Social media-only sellers: Legitimate providers have proper websites and licensing
- Pressure tactics: "Limited time" offers or urgency to purchase immediately
- Celebrity endorsements: Many are fabricated using AI-generated content
- No provider evaluation: You should be medically evaluated before receiving GLP-1 medication
FTC Enforcement Actions
The FTC has taken multiple enforcement actions in the GLP-1 space. Notable actions include sending cease-and-desist letters to supplement companies making unsupported GLP-1 claims, filing complaints against companies using deceptive advertising for weight loss products, coordinating with the FDA to shut down unlicensed online pharmacies, and issuing consumer alerts about specific scam patterns in the weight loss market.
How to Identify Legitimate Providers
Legitimate Provider Checklist
- Licensed medical providers conduct your evaluation
- A valid prescription is required before dispensing
- Pharmacy partners are US-licensed and verifiable
- Pricing is transparent with no hidden fees
- No guaranteed specific weight loss amounts
- Medical history and contraindications are reviewed
- Contact information and support are readily available
- Business is registered and has a physical address
How to Report GLP-1 Fraud
If you encounter a suspected GLP-1 scam, report it to the FTC at ReportFraud.ftc.gov, the FDA's MedWatch program for unsafe medical products, your state attorney general's consumer protection division, and the Better Business Bureau. Your report helps protect other consumers and provides evidence for enforcement actions.
Protecting Yourself
The simplest protection is working with established, transparent providers. Compounded semaglutide and tirzepatide from Trimi are prescribed by licensed providers, dispensed by licensed pharmacies, and priced transparently at $125/mo and $125/mo respectively with no hidden fees. If a deal seems too good to be true, it probably is.
The Bottom Line
As the GLP-1 market grows, so does the scam ecosystem surrounding it. Protect yourself by working with reputable providers, requiring proper medical evaluation, verifying pharmacy licensing, and reporting fraud when you see it. The FTC is actively enforcing, but informed consumers are the best defense against GLP-1 fraud.
Trusted GLP-1 Treatment from Trimi
Licensed providers, licensed pharmacies, transparent pricing. Semaglutide $99/mo, tirzepatide $125/mo.
View OptionsMore on legal & regulatory
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).